Weixun Wang is an accomplished pharmaceutical executive currently serving as the Director of Pharmacokinetics at Merck, where they lead an Analytical & Translational Pharmacology group. With extensive experience in bioanalysis, Weixun has supported drug development through the implementation of bioanalytical strategies and the establishment of translational biomarker workflows. Prior to Merck, they held positions at SurroMed and Intel Corporation, contributing to advancements in quantitative proteomics and ultra-sensitive protein detection platforms. Weixun earned a B.S. in Chemistry from Peking University and is pursuing a Ph.D. in Chemistry at Princeton University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices